Thermal alterations in patients with inflammatory diseases: a comparison between psoriatic and rheumatoid arthritis
Submitted: 28 July 2017
Accepted: 8 January 2018
Published: 20 December 2018
Accepted: 8 January 2018
Abstract Views: 1325
PDF: 931
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- M. Gutierrez, E. Filippucci, R. De Angelis, C. Bertolazzi, A. Becciolini, A. Ariani, W. Grassi, The ultrasound assessment of the psoriatic arthritis: from joint to skin , Reumatismo: Vol. 61 No. 4 (2009)
- N. Busso, H.-K. Ea, The mechanisms of inflammation in gout and pseudogout (CPP-induced arthritis) , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- P. Sarzi- Puttini, F. Atzeni, E. Lubrano, Complementary medicine in rheumatoid arthritis , Reumatismo: Vol. 57 No. 4 (2005)
- A. Laria, A. Zoli, E. Gremese, G.F. Ferraccioli, Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections , Reumatismo: Vol. 63 No. 1 (2011)
- S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi, Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis , Reumatismo: Vol. 62 No. 1 (2010)
- M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula, Prevalence of anti-CCP antibodies in systemic sclerosis , Reumatismo: Vol. 59 No. 1 (2007)
- C. Botsios, P. Ostuni, S. Todesco, Incidence and management of infusion reactions to infliximab in 186 italian patient’s with rheumatoid arthritis: the Padua experience , Reumatismo: Vol. 57 No. 1 (2005)
- M.A. Cimmino, EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS , Reumatismo: Vol. 59 No. s1 (2007)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri, The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature , Reumatismo: Vol. 70 No. 2 (2018)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
You may also start an advanced similarity search for this article.